🔎 Trials Near Me

Pradžia › Antsvoris › Rhode Island

Antsvoris klinikiniai tyrimai Rhode Island

13 tyrimai dėl Antsvoris ieško dalyvių vietose Rhode Island.

Miestai Rhode Island

Oficialus tyrimo tekstas (anglų kalba)

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

  • Clinical Res Collaborative, Cumberland
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07720271

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  • University Gastroenterology, Providence
Renkami dalyviai3 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-24 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • University Gastroenterology, Providence
Renkami dalyviai3 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-24 · NCT06937086

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Velocity Clinical Research - Providence, East Greenwich
Renkami dalyviai3 fazė
Amžius nuo 45 iki 99 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07037433

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

  • Kailera Clinical Site, East Greenwich
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-03 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

  • Velocity Clinical Research - Providence, East Greenwich
Renkami dalyviai3 fazė
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-09-03 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

  • Velocity Clinical Research - Providence, East Greenwich
Renkami dalyviai3 fazė
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-09-03 · NCT07684144

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

  • Women and Infants Hospital of Rhode Island, Providence
Renkami dalyviai
Amžius nuo 18 iki 45 · Moterims · Atnaujinta 2026-06-24 · NCT05124808

Brain and Behavior Influences on Obesity Development From Infancy Through Childhood

  • Rhode Island Hospital, Providence
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 7 iki 12 · Visoms lytims · Atnaujinta 2026-05-07 · NCT06861868

Microrandomized Trial to Optimize Use of Burden-reducing Self-monitoring Approaches in Behavioral Obesity Treatment

  • The Weight Control and Diabetes Research Center of The Miriam Hospital & Brown University, Providence
Renkami dalyviai
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-02-04 · NCT07228130

Pilot Test of Five Weight Neutral Interventions to Improve Health Among Adults of Higher Body Weight

  • Weight Control and Diabetes Research Center, Providence
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-01-23 · NCT07363616

Weight Management Intervention in College: A Pilot

  • The Miriam Hospital, Providence
Renkami dalyviai
Amžius nuo 18 iki 29 · Visoms lytims · Atnaujinta 2025-10-01 · NCT06994923

Control Systems Engineering for Weight Loss Maintenance

  • Miriam Hospital Weight Control and Diabetes Resarch Center, Providence
Renkami dalyviai2 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2024-04-02 · NCT06244888

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.